article · International Journal of Medicine and Health Development
Background: A key step in the detection of suicide risk in a primarily nonpsychiatric population will be the use of a simple brief self-reported psychometrically valid and reliable instrument that does not require prior training to administer. Objective: This study aimed to explore the possibility of adapting the 14‑item hospital anxiety and depression scale (HADS) as a self-rated suicide risk screening tool in a sample of Nigerian surgical patients. Materials and Methods: This is a cross-sectional study involving 462 Nigerian patients attending a surgical outpatient clinic. They completed the Sociodemographic questionnaire, the 14-item HADS, the suicidality module of the Mini‑International Neuropsychiatric Interview, and the brief version of the World Health Organization Quality of Life Questionnaire. The reliabilities of the HADS-anxiety and depression subscales were evaluated by calculating the omega (ω) coefficients. Receiver operating characteristics curve analysis was performed to determine the suicide risk screening characteristics of the HADS-anxiety and depression subscales. Results: The omega (ω) reliability coefficients of the HADS subscales were satisfactory. At a cutoff score of 10 HADS-anxiety subscale exhibited satisfactory sensitivity (0.750) and specificity (0.938) while the HADS-Depression subscale at a cutoff score of 7 had the best combination of sensitivity (0.750) and specificity (0.905). The prevalence rate of lifetime suicide attempts in our sample was 1.5%, whereas 1.8% of our respondents had high suicide risk. Conclusion: The 14-item HADS has shown to be a suitable self-rated suicide risk assessment tool among Nigerian surgical patients.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/ijmh.ijmh_34_23
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.